Andrew S. Bae

Baseline genotype as a predictor of virological failure to emtricitabine or stavudine in combination with didanosine and efavirenz.

K. Borroto-Esoda, J. Hinkle, J. Quinn, 2007, AIDS research and human retroviruses.

Low-Level K65R Mutation in HIV-1 Reverse Transcriptase of Treatment-Experienced Patients Exposed to Abacavir or Didanosine

K. Borroto-Esoda, Lijie Zhong, E. Svarovskaia, 2007, Journal of acquired immune deficiency syndromes.

Susceptibility of Treatment-Naive Hepatitis C Virus (HCV) Clinical Isolates to HCV Protease Inhibitors

H. Mo, Xiaowu Chen, Karin S. Ku, 2010, Antimicrobial Agents and Chemotherapy.

Characterization of Resistance to the Protease Inhibitor GS-9451 in Hepatitis C Virus-Infected Patients

H. Mo, P. Pang, H. Dvory‐Sobol, 2012, Antimicrobial Agents and Chemotherapy.

Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial.

J. Kurtzberg, J. Englund, Marion E. Morrison, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Natural variation in drug susceptibility to HCV polymerase inhibitors in treatment‐naïve HCV patient isolates

H. Mo, M. D. Miller, X. Qi, 2011, Journal of viral hepatitis.

Characterization of Resistance to the Protease Inhibitor GS-9451 in Hepatitis C Virus-Infected Patients

H. Mo, P. Pang, H. Dvory‐Sobol, 2012, Antimicrobial Agents and Chemotherapy.

Development of a replicon-based phenotypic assay for assessing the drug susceptibilities of HCV NS3 protease genes from clinical isolates.

H. Mo, Huiling Yang, W. Delaney, 2009, Antiviral research.

MultiCode-RTx Real-Time PCR System for Detection of Subpopulations of K65R Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutant Viruses in Clinical Samples

M. Moser, K. Borroto-Esoda, J. Prudent, 2006, Journal of Clinical Microbiology.